<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39446250</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-2443</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>24</Day></PubDate></JournalIssue><Title>Journal of neurovirology</Title><ISOAbbreviation>J Neurovirol</ISOAbbreviation></Journal><ArticleTitle>A systematic analysis of neurologic manifestations of Long COVID in Nigeria.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13365-024-01232-9</ELocationID><Abstract><AbstractText>Long COVID, also called post-acute sequelae of SARS-CoV-2 infection (PASC) affects millions of people in the world. The neurologic manifestations of PASC (Neuro-PASC) are among the most debilitating but they are largely unreported in Africa. We sought to compare the demographics, symptoms and cognitive profile of post-hospitalization Neuro-PASC (PNP) and non-hospitalized Neuro-PASC (NNP) patients in Nigeria. In this cross-sectional study performed at the Lagos University Teaching Hospital, 106/2319 (4.6%) SARS-CoV-2 positive individuals contacted via telephone reported Neuro-PASC symptoms with a higher frequency in PNP than in NNP individuals ((23/200 (11.5%) vs. 83/2119 (3.9%), p&#x2009;=&#x2009;&lt;&#x2009;0.0001). The predominant neurologic symptoms at any time during the disease course were difficulty remembering / brain fog (63/106; 59.4%), fatigue (59/106; 55.7%), sleep problems (34/106; 32%), headache (33/106; 31%), paresthesia (12/106; 11.3%), and myalgia (10/106; 9.4%). Of 66 participants with Neuro-PASC who underwent in-person neurological evaluation and cognitive screening, all had normal scores on the Intervention for Dementia in Elderly Africans cognition screen, while 11/65 (16.9%) that completed the Montreal Cognitive Assessment had results consistent with mild cognitive impairment (3/16 PNP (18.8%) and 8/49 NNP (16.3%); p&#x2009;=&#x2009;1.0). Finally, 47/66 (71.2%) had digit span test scores consistent with mild cognitive dysfunction (12/16 PNP (75%) and 35/50 (70%) NNP; p&#x2009;=&#x2009;1.0). Our findings reveal the previously unrecognized occurrence of Neuro-PASC among COVID-19 survivors in Nigeria and highlight the need for improved screening and diagnosis of Neuro-PASC in our population. Development of cognitive support services for persons suffering from Neuro-PASC in Nigeria is warranted.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s) under exclusive licence to The Journal of NeuroVirology, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akase</LastName><ForeName>Iorhen Ephraim</ForeName><Initials>IE</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Idi Araba, Lagos State, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Lagos University Teaching Hospital, Idi Araba, Lagos State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agabi</LastName><ForeName>Osigwe Paul</ForeName><Initials>OP</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Idi Araba, Lagos State, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Lagos University Teaching Hospital, Idi Araba, Lagos State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ojo</LastName><ForeName>Oluwadamilola Omolara</ForeName><Initials>OO</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Idi Araba, Lagos State, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Lagos University Teaching Hospital, Idi Araba, Lagos State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anyanwu</LastName><ForeName>Roosevelt Amaobichukwu</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Central Research Laboratory, College of Medicine, University of Lagos, Idi Araba, Lagos State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Awodumila</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Idi Araba, Lagos State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayilara</LastName><ForeName>Sodiq</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Idi Araba, Lagos State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ede</LastName><ForeName>Obiamaka Jane</ForeName><Initials>OJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Lagos University Teaching Hospital, Idi Araba, Lagos State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghajiga</LastName><ForeName>Pheekanmilla</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Idi Araba, Lagos State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalejaiye</LastName><ForeName>Olufunto</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Idi Araba, Lagos State, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Lagos University Teaching Hospital, Idi Araba, Lagos State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nwanmah</LastName><ForeName>Chibueze</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Idi Araba, Lagos State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nwaokorie</LastName><ForeName>Francisca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory Science, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, Idi Araba, Lagos State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogbenna</LastName><ForeName>Ann</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Hematology &amp; Blood Transfusion, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Idi Araba, Lagos State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olajide</LastName><ForeName>Moyinoluwa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Idi Araba, Lagos State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perez-Giraldo</LastName><ForeName>Gina S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orban</LastName><ForeName>Zachary Steven</ForeName><Initials>ZS</Initials><AffiliationInfo><Affiliation>Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimenez</LastName><ForeName>Millenia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koralnik</LastName><ForeName>Igor Jerome</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Division of Neuro-Infectious Diseases and Global Neurology, Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. igor.koralnik@northwestern.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okubadejo</LastName><ForeName>Njideka Ulunma</ForeName><Initials>NU</Initials><AffiliationInfo><Affiliation>Department of Medicine, Faculty of Clinical Sciences, College of Medicine, University of Lagos, Idi Araba, Lagos State, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Lagos University Teaching Hospital, Idi Araba, Lagos State, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Catalyzer award # 1055</GrantID><Agency>Robert J. Havey Institute for Global Health, Northwestern University, Feinberg School of Medicine</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurovirol</MedlineTA><NlmUniqueID>9508123</NlmUniqueID><ISSNLinking>1355-0284</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Mild cognitive impairment</Keyword><Keyword MajorTopicYN="N">Neurology</Keyword><Keyword MajorTopicYN="N">Nigeria</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of SARS-CoV-2 infection (PASC)</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>24</Day><Hour>11</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39446250</ArticleId><ArticleId IdType="doi">10.1007/s13365-024-01232-9</ArticleId><ArticleId IdType="pii">10.1007/s13365-024-01232-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Adebisi YA, Rabe A, Lucero-Prisno Iii DE (2021) COVID-19 surveillance systems in African countries. Health Promot Perspect 11:382&#x2013;392</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/hpp.2021.49</ArticleId><ArticleId IdType="pubmed">35079582</ArticleId><ArticleId IdType="pmc">8767077</ArticleId></ArticleIdList></Reference><Reference><Citation>Africa Centres for Disease Control and Prevention COVID-19. https://africacdc.org/covid-19/</Citation></Reference><Reference><Citation>Aguwa C, Carrasco T, Odongo N, Riblet N (2022) Barriers to treatment as a hindrance to Health and Wellbeing of individuals with Mental illnesses in Africa: a systematic review. Int J Ment Health Addict 24:2354&#x2013;2370 https://doi.org/10.1007/s11469-021-00726-5</Citation></Reference><Reference><Citation>Bailey J, Lavelle B, Miller J, Jimenez M, Lim PH, Orban ZS, Clark JR, Tomar R, Ludwig A, Ali ST, Lank GK, Zielinski A, Mylvaganam R, Kalhan R, Muayed ME, Mutharasan RK, Liotta EM, Sznajder JI, Davidson C, Koralnik IJ, Sala MA (2023) Northwestern Medicine Comprehensive, C.C.I., Multidisciplinary Center Care for Long COVID Syndrome - a Retrospective Cohort Study. Am J Med</Citation></Reference><Reference><Citation>Callard F, Perego E (2021) How and why patients made Long Covid. Soc Sci Med 268:113426</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId><ArticleId IdType="pmc">7539940</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheyne I, Gopinath VS, Muppa N, Armas AE, Gil Agurto MS, Akula SA, Nagpal S, Yousaf MS, Haider A (2024) The neurological implications of COVID-19: a Comprehensive Narrative Review. Cureus 16, e60376</Citation></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P (2021) Long covid-mechanisms, risk factors, and management. BMJ 374:n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ (2023) Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21:133&#x2013;146</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId><ArticleId IdType="pmc">9839201</ArticleId></ArticleIdList></Reference><Reference><Citation>Desgranges F, Tadini E, Munting A, Regina J, Filippidis P, Viala B, Karachalias E, Suttels V, Haefliger D, Kampouri E, Van Singer M, Tschopp J, Stettler R, Schaad L, Brahier S, Hugli T, Mueller O, Gouveia Y, Opota A, Carron O, Guery PN, Papadimitriou-Olivgeris B, Boillat-Blanco M, Group N, t.R.R (2022) Post&#x2013;COVID&#x2013;19 syndrome in outpatients: a Cohort Study. J Gen Intern Med 37:1943&#x2013;1952</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-07242-1</ArticleId><ArticleId IdType="pubmed">35319081</ArticleId><ArticleId IdType="pmc">8939498</ArticleId></ArticleIdList></Reference><Reference><Citation>Egbe CO, Brooke-Sumner C, Kathree T, Selohilwe O, Thornicroft G, Petersen I (2014) Psychiatric stigma and discrimination in South Africa: perspectives from key stakeholders. BMC Psychiatry 14:191</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-244X-14-191</ArticleId><ArticleId IdType="pubmed">24996420</ArticleId><ArticleId IdType="pmc">4099203</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Yang D, Lewis A, Patel P, Medicherla C, Arena V, Fang T, Andino A, Snyder T, Madhavan M, Gratch D, Fuchs B, Dessy A, Canizares M, Jauregui R, Thomas B, Bauman K, Olivera A, Bhagat D, Sonson M, Park G, Stainman R, Sunwoo B, Talmasov D, Tamimi M, Zhu Y, Rosenthal J, Dygert L, Ristic M, Ishii H, Valdes E, Omari M, Gurin L, Huang J, Czeisler BM, Kahn DE, Zhou T, Lin J, Lord AS, Melmed K, Meropol S, Troxel AB, Petkova E, Wisniewski T, Balcer L, Morrison C, Yaghi S, Galetta S (2021) A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J Neurol Sci 426:117486</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117486</ArticleId><ArticleId IdType="pubmed">34000678</ArticleId><ArticleId IdType="pmc">8113108</ArticleId></ArticleIdList></Reference><Reference><Citation>Galea M, Agius M, Vassallo N (2022) Neurological manifestations and pathogenic mechanisms of COVID-19. Neurol Res 44:571&#x2013;582</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01616412.2021.2024732</ArticleId><ArticleId IdType="pubmed">34986754</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, DiBiase RM, Jia DT, Balabanov R, Ho SU, Batra A, Liotta EM, Koralnik IJ (2021) Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 long haulers. Ann Clin Transl Neurol 8:1073&#x2013;1085</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId><ArticleId IdType="pmc">8108421</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, Lekoubou A, Oh JS, Ericson JE, Ssentongo P, Chinchilli VM (2021) Short-term and long-term rates of Postacute Sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open 4, e2128568</Citation></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)&#x2014;a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377&#x2013;381. https://www.sciencedirect.com/science/article/pii/S1532046408001226</Citation></Reference><Reference><Citation>Kim S, Lee H, Lee J, Lee SW, Kwon R, Kim MS, Koyanagi A, Smith L, Fond G, Boyer L, Rahmati M, Sanchez L, Dragioti GF, Cortese E, Shin S, Choi JY, Suh A, Lee HS, Solmi S, Min M, Shin C, Yon JI, Fusar-Poli DK, P (2024) Short- and long-term neuropsychiatric outcomes in long COVID in South Korea and Japan. Nat Hum Behav</Citation></Reference><Reference><Citation>Leung JL, Lee GT, Lam YH, Chan RC, Wu JY (2011) The use of the Digit Span Test in screening for cognitive impairment in acute medical inpatients. Int Psychogeriatr 23:1569&#x2013;1574</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1041610211000792</ArticleId><ArticleId IdType="pubmed">21729426</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotta EM, Batra A, Clark JR, Shlobin NA, Hoffman SC, Orban ZS, Koralnik IJ (2020) Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol 7:2221&#x2013;2230</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51210</ArticleId><ArticleId IdType="pubmed">33016619</ArticleId><ArticleId IdType="pmc">7664279</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID Household Pulse Survey. National Center for Health Statistic &amp; US Census Bureau. https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm</Citation></Reference><Reference><Citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B (2020) Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol 77:683&#x2013;690</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelsohn AS, Nath N, De Sa A, Von Pressentin KB (2022) Two months follow-up of patients with non-critical COVID-19 in Cape Town, South Africa. S Afr Fam Pract (2004) 64, e1-e6</Citation></Reference><Reference><Citation>Moghimi N, Di Napoli M, Biller J, Siegler JE, Shekhar R, McCullough LD, Harkins MS, Hong E, Alaouieh DA, Mansueto G, Divani AA (2021) The neurological manifestations of Post-acute Sequelae of SARS-CoV-2 infection. Curr Neurol Neurosci Rep 21:44</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-021-01130-1</ArticleId><ArticleId IdType="pubmed">34181102</ArticleId><ArticleId IdType="pmc">8237541</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695&#x2013;699</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53221.x</ArticleId><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunn AVW, Guy GW, Brysch W, Bell JD (2022) Understanding Long COVID; Mitochondrial Health and Adaptation-Old Pathways, New Problems. Biomedicines 10.</Citation></Reference><Reference><Citation>Okoroiwu HU, Ogar CO, Nja GME, Abunimye DA, Ejemot-Nwadiaro RI (2021) COVID-19 in Nigeria: account of epidemiological events, response, management, preventions and lessons learned. Germs 11:391&#x2013;402</Citation><ArticleIdList><ArticleId IdType="doi">10.18683/germs.2021.1276</ArticleId><ArticleId IdType="pubmed">34722361</ArticleId><ArticleId IdType="pmc">8548039</ArticleId></ArticleIdList></Reference><Reference><Citation>Ondoa P, Kebede Y, Loembe MM, Bhiman JN, Tessema SK, Sow A, Sall AA, Nkengasong J (2020) COVID-19 testing in Africa: lessons learnt. Lancet Microbe 1:e103&#x2013;e104</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(20)30068-9</ArticleId><ArticleId IdType="pubmed">32835338</ArticleId><ArticleId IdType="pmc">7333988</ArticleId></ArticleIdList></Reference><Reference><Citation>Paddick SM, Gray WK, Ogunjimi L, Lwezuala B, Olakehinde O, Kisoli A, Kissima J, Mbowe G, Mkenda S, Dotchin CL, Walker RW, Mushi D, Collingwood C, Ogunniyi A (2015) Validation of the Identification and Intervention for Dementia in Elderly africans (IDEA) cognitive screen in Nigeria and Tanzania. BMC Geriatr 15:53</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12877-015-0040-1</ArticleId><ArticleId IdType="pubmed">25908439</ArticleId><ArticleId IdType="pmc">4455989</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez Giraldo GS, Ali ST, Kang AK, Patel TR, Budhiraja S, Gaelen JI, Lank GK, Clark JR, Mukherjee S, Singer T, Venkatesh A, Orban ZS, Lim PH, Jimenez M, Miller J, Taylor C, Szymanski AL, Scarpelli J, Graham EL, Balabanov RD, Barcelo BE, Cahan JG, Ruckman K, Shepard AG, Slutzky MW, LaFaver K, Kumthekar PU, Shetty NK, Carroll KS, Ho SU, Lukas RV, Batra A, Liotta EM, Koralnik IJ (2023) Neurologic manifestations of Long COVID Differ based on Acute COVID-19 severity. Ann Neurol 94:146&#x2013;159</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26649</ArticleId><ArticleId IdType="pubmed">36966460</ArticleId></ArticleIdList></Reference><Reference><Citation>Peter RS, Nieters A, Krausslich HG, Brockmann SO, Gopel S, Kindle G, Merle U, Steinacker JM, Rothenbacher D, Kern WV, Group EPS (2022) Post-acute sequelae of covid-19 six to 12 months after infection: population based study. BMJ 379, e071050</Citation></Reference><Reference><Citation>Septyaningtrias DE, Susilowati R (2021) Neurological involvement of COVID-19: from neuroinvasion and neuroimmune crosstalk to long-term consequences. Rev Neurosci 32:427&#x2013;442</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2020-0092</ArticleId><ArticleId IdType="pubmed">33550780</ArticleId></ArticleIdList></Reference><Reference><Citation>Strachan DP (2000) Family size, infection and atopy: the first decade of the hygiene hypothesis. Thorax 55(Suppl 1):2&#x2013;10</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thorax.55.suppl_1.S2</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, Taverner T, Chandan JS, Brown K, Simms-Williams N, Shah AD, Singh M, Kidy F, Okoth K, Hotham R, Bashir N, Cockburn N, Lee SI, Turner GM, Gkoutos GV, Aiyegbusi OL, McMullan C, Denniston AK, Sapey E, Lord JM, Wraith DC, Leggett E, Iles C, Marshall T, Price MJ, Marwaha S, Davies EH, Jackson LJ, Matthews KL, Camaradou J, Calvert M, Haroon S (2022) Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med 28:1706&#x2013;1714</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId><ArticleId IdType="pmc">9388369</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas LS, Molteni E, Modat M, Cardoso J, May M, Ganesh A, Davies S, Nguyen R, Drew LH, Astley DA, Joshi CM, Merino AD, Tsereteli J, Fall N, Gomez T, Duncan MF, Menni EL, Williams C, Franks FMK, Chan PW, Wolf AT, Ourselin J, Spector S, Steves T, C.J (2021) Attributes and predictors of long COVID. Nat Med 27:626&#x2013;631</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId><ArticleId IdType="pmc">7611399</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Sillett R, Zhu L, Mendel J, Camplisson I, Dercon Q, Harrison PJ (2022) Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry</Citation></Reference><Reference><Citation>Tawiah PE, Adongo PB, Aikins M (2015) Mental Health-related stigma and discrimination in Ghana: experience of patients and their caregivers. Ghana Med J 49:30&#x2013;36</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/gmj.v49i1.6</ArticleId><ArticleId IdType="pubmed">26339082</ArticleId><ArticleId IdType="pmc">4549818</ArticleId></ArticleIdList></Reference><Reference><Citation>Visvabharathy L, Hanson BA, Orban ZS, Lim PH, Palacio NM, Jimenez M, Clark JR, Graham EL, Liotta EM, Tachas G, Penaloza-MacMaster P, Koralnik IJ (2023) Neuro-PASC is characterized by enhanced CD4&#x2009;+&#x2009;and diminished CD8&#x2009;+&#x2009;T cell responses to SARS-CoV-2 nucleocapsid protein. Front Immunol 14:1155770</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1155770</ArticleId><ArticleId IdType="pubmed">37313412</ArticleId><ArticleId IdType="pmc">10258318</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO) Coronavirus (COVID-19) Dashboard. https://covid19.who.int/</Citation></Reference><Reference><Citation>Yomogida K, Zhu S, Rubino F, Figueroa W, Balanji N, Holman E (2021) Post-acute Sequelae of SARS-CoV-2 infection among adults aged &gt;/=18 years - Long Beach, California, April 1-December 10, 2020. MMWR Morb Mortal Wkly Rep 70:1274&#x2013;1277</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7037a2</ArticleId><ArticleId IdType="pubmed">34529639</ArticleId><ArticleId IdType="pmc">8445372</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>